High-dose vitamin E linked to increased mortality
|
Tweet
|
|
Taking a high dose of vitamin E routinely does not increase your chances of living longer, and in fact it seems to have a negative effect.
Vitamin E supplementation at doses higher than 400 International Units (IU) per day apparently raises all-cause mortality rates and should be avoided, a research team reported at the American Heart Association meeting. Their findings are also being published by the Annals of Internal Medicine online November 10.
Because of its antioxidant properties, vitamin E supplementation has been studied in many trials to prevent chronic diseases. Several of those studies have hinted at increased mortality rates, but the number of participants in the each study was too small to tell if the results were real or occurred by chance.
To further investigate, Dr. Edgar R. Miller III, at Johns Hopkins Medical Institutions in Baltimore, and his team pooled data from 19 trials of vitamin E supplementation. These included nearly 136,000 subjects who were randomly assigned to take vitamin E or placebo capsules and were followed for more than a year.
Overall, vitamin E supplementation did not affect mortality rates, the team found.
However, the 11 trials testing doses of 400 IU daily or higher showed 39 more deaths occurred per 10,000 people taking high-dose vitamin E than among the same number of people taking a placebo.
Miller’s group calculates that the risk of dying was increase by 4 percent with high-dose vitamin E.
For low doses of vitamin E—less than 150 IU daily—all-cause mortality rates were slightly decreased, although this difference was not significant from a statistical standpoint.
When the researchers factored in the simultaneous use of other vitamins or minerals, the reduction in the risk of dying with low-dosage vitamin E was toned down, but the risk at higher doses was increased.
“On the basis of our study, high-dosage vitamin E supplementation is clearly unjustified,” the authors say in their article.
They point out that current guidelines recommend the use of vitamin E to delay the progression of Alzheimers disease, a recommendation that “may be premature until larger randomized, controlled clinical trials evaluate the efficacy and safety of high-dosage vitamin E supplementation.”
SOURCE: Annals of Internal Medicine, November 10 online, 2004.
Revision date: June 20, 2011
Last revised: by David A. Scott, M.D.
| RELATED STORIES: | ||
| Comments | [ + Post Your Own ] |
Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.
There are no comments for this entry yet. [ + Comment here + ]
We are pleased to let readers post comments about an article. Please increase the credibility of your post by including your full name and email.
All comments are reviewed by our editors before they are posted on the site. Just keep it clean, kids.
- Full Story - - »»»
Best time for a coffee break? There’s an app for that
- Full Story - - »»»
Cellphone Use Linked to Selfish Behavior in UMD Study
- Full Story - - »»»
Optimism about heart risks may be a good thing
- Full Story - - »»»
New guidelines developed for improved DVT diagnosis
- Full Story - - »»»
Teen pregnancy, abortion rates at record low, study says
- Full Story - - »»»
Think you can’t get pregnant? Try again, study says
- Full Story - - »»»

